Investigation of bacterial and viral agents and immune status in Behcet's disease patients from Iran

International Journal of Rheumatic Diseases

Volumn 14, Issue 3, 2011, Pages 298-310

  Irschick, Eveline U ^a   Philipp, Sebastian ^a   Shahram, Farhad ^b   Schirmer, Michael ^c   Sedigh, Massih ^b   Ziaee, Naghmeh ^b   Gassner, Christoph ^a   Schennach, Harald ^a   Meyer, Martina ^a   Larcher, Clara ^d   Herold, Manfred ^c   Schoenitzer, Dieter ^a   Fuchs, Dietmar ^e   Schoenbauer, Michael ^f   Maass, Matthias ^g   Huemer, Hartwig P ^d   Davatchi, Fereydoun ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e UNIVERSITY OF INNSBRUCK   (Austria)

^f AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^g St Johanns Spital   (Austria)

Author keywords

Bacteria; Behcet's disease; Cytokines; HLA B51 subtyping; Neopterin; Virus

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; KYNURENINE; LEUKOCYTE ANTIGEN; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANIMAL CELL; ANTIBODY DETECTION; APHTHOUS STOMATITIS; ARTICLE; BACTERIUM DETECTION; BEHCET DISEASE; CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLONY FORMING UNIT; CONTROLLED STUDY; COXIELLA; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; ERYTHEMA NODOSUM; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN PARVOVIRUS B19; IMMUNE RESPONSE; IRAN; LEPTOSPIRA; LISTERIA; MALE; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; PANOPHTHALMITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMATITIS; VIRUS DETECTION; YERSINIA;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; BEHCET SYNDROME; CHILD; DNA, BACTERIAL; DNA, VIRAL; FEMALE; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HUMANS; INTERLEUKINS; IRAN; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; SEROEPIDEMIOLOGIC STUDIES; TUMOR NECROSIS FACTOR-ALPHA; VIRUS DISEASES; YOUNG ADULT;

EID: 79961172076     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2011.01601.x     Document Type: Article

References (46)

1. Yazici H (2003) Behcet's syndrome: an update. Curr Rheumatol Rep 5, 195-9.
2. Behcet H (1937) Über rezidivierende aphtöse, durch ein Virus verursachte Geschwuere am Mund, am Auge und an den Genitalien (About recitivating aphtous ulcers on mouth, eye and the genitals caused by a virus). Derm Wschr 105, 1152-63.
3. Akaogi J, Yotsuyanagi H, Sugata F, Matsuda T, Hino K (2000) Hepatitis viral infection in Behcet's disease. Hepatol Res 17, 126-38.
4. Aksu K, Kabasakal Y, Sayiner A, et al. (1999) Prevalences of hepatitis A, B, C and E viruses in Behcet's disease. Rheumatology 38, 1279-81.
5. Kiraz S, Öztürk MA, Ertenli I, Calgüneri M (2001) Parvovirus B19 infection in Behcet's disease. Ann Rheum Dis 60, 814-5.
6. Studd M, McCance DJ, Lehner T (1991) Detection of HSV-1 DNA in patients with Behcet's syndrome and in patients with recurrent oral ulcers by polymerase chain reaction. J Med Microbiol 34, 39-43.
7. Eglin RP, Lehner T, Subak-Sharpe JH (1982) Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers. Lancet 2, 1356-61.
8. Sohn S, Lee E, Kwon HJ, Lee SI, Bang D, Lee S (2001) Expression of Th2 cytokines decreases the development of and improves Behcet's-disease-like symptoms induced by herpes simplex virus in mice. J Infect Dis 183, 1180-6.
9. Sohn S, Lee E, Bang D, Lee S (2003) Role of infectious organisms in Behcet's disease. In: Zierhut M, Ohno S (eds) Immunology of Behcet's Disease, pp 103-11. Swets & Zeitlinger, Lisse, the Netherlands.
10. Hirohata S, Oka H, Mizushima Y (1992) Streptococcal-related antigens stimulate production of IL 6 and interferon gamma by T cells from patients with Behcet's disease. Cell Immunol 140, 410-9.
11. Stuebiger N, Zierhut M, Kötter I (2003) Ocular manifestations in Behcet's disease. In: Zierhut M, Ohno S (eds) Immunology of Behcet's Disease, pp 37-45. Swets & Zeitlinger, Lisse, the Netherlands.
12. Mueller CA, Günaydin I, Stuebiger N, et al. (2003) Association of HLA-B51 suballeles with Behcet's disease in patients of German and Turkish origin. In: Zierhut M, Ohno S (eds) Immunology of Behcet's Disease, pp 121-6. Swets & Zeitlinger, Lisse, the Netherlands.
13. Zouboulis CC, Büttner P, Tebbe B, Orfanos CE (1993) Anticardiolipin antibodies in Adamantiades-Behcet's disease. Br J Dermatol 128, 281-4.
14. Toydemir PB, Elhan AH, Tükün A, et al. (2000) Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothrombin gene G20210A mutations on deep venous thrombosis in Behcet's disease. J Rheumatol 27, 2849-54.
15. Aydintug AO, Tokgoz G, D'Cruz DP, et al. (1993) Antibodies to endothelial cells in patients with Behcet's disease. Clin Immunol Immunopathol 67, 157-62.
16. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Kaczmarski EB, Fox AJ (2000) Contamination and sensitivity issues with real-time universal 16S rRNA PCR. J Clin Microbiol 38, 1747-52.
17. İlter N, Şenol E, Gürer MA, Öztaş MO (2000) Behcet's disease and HCV infection. Int J Dermatol 39, 396-7.
18. Nomura Y, Kitteringham N, Shiba K, Goseki M, Kimura A, Mineshita S (1998) Use of highly sensitive PCR method to detect the Herpes simplex virus type 1 genome and its expression in samples from Behcet disease patients. J Med Dent Sci 45, 51-8.
19. Hamzaoui K, Ayden K, Slim A, Hamza M, Touraine J (1990) Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behcet's disease. Clin Exp Immunol 79, 28-34.
20. Avci O, Ellidokuz E, Simsek I, Buyukgebiz B, Gunes AT (1999) Helicobacter pylori and Behcet's disease. Dermatology 199, 140-3.
21. Zouboulis CC, Turnbull JR, Mühlradt PF (2003) High seroprevalence of anti-mycoplasma fermentans antibodies in patients with malignant aphthosis. J Invest Dermatol 121, 211-3.
22. Barta Z, Csipo I, Mekkel G, Zeher M, Majoros L (2004) Seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease. J Clin Microbiol 42, 5432-3.
23. Naser SA, Ghobrial G, Romero C, Valentine JF (2004) Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364, 1039-44.
24. El-Zaatari FAK, Naser S, Markesich DC, Kalter DC, Engstand L, Graham DY (1996) Identification of Mycobacterium avium complex in sarcoidodis. J Clin Microbiol 34, 2240-5.
25. Kaneko F, Takahashi Y, Muramatsu Y, Miura Y (1985) Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behcet's disease. Br J Dermatol 113, 303-12.
26. Gaya DR, Black RA, MacKenzie JF (2004) Crohn's disease and MAP. Lancet 364, 2179.
27. Nadkarni MA, Martin FE, Jacques NA, Hunter N (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primer set. Microbiology 148, 257-66.
28. Carroll NM, Adamson P, Okhravi N (1999) Elimination of bacterial DNA from Taq DNA polymerase by restriction endonuclease digestion. J Clin Microbiol 37, 3402-4.
29. Okhravi N, Adamson P, Matheson MM, Towler HMA, Lightman S (2000) PCR-RFLP-mediated detection and speciation of bacterial species causing endophthalmitis. Invest Ophthalmol Vis Sci 41, 1438-47.
30. Philipp S, Huemer HP, Irschick EU, Gassner C (2010) Obstacles of multiplex real-time PCR for bacterial 16S rDNA: primer specificity and DNA decontamination of Taq polymerase. Transfus Med Hemother 37, 21-8.
31. Kaya TI, Tursen U, Gurler A, Durt H (2002) Association of class I HLA antigens with clinical manifestations of Turkish patients with Behcet's disease. Clin Exp Dermatol 27, 498-501.
32. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Behcet's disease the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54, 213-20.
33. Mizuki N, Ota M, Katsuyama Y, et al. (2001) HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behcet's disease. Tissue Antigens 58, 181-4.
34. Davatchi F, Shahram F, Chams C, et al. (2003) Non-ocular manifestations. In: Zierhut M, Ohno S (eds) Immunology of Behcet's Disease, pp 21-35. Swets & Zeitlinger, Lisse, the Netherlands.
35. Mizuki N, Ota M, Katsuyama Y, et al. (2001) HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behcet's disease. Tissue Antigens 57, 457-62.
36. Shahram F, Davatchi F, Nadji A, et al. (2003) HLA-B51 frequency in Iranian patients with Behcet's disease. Adv Exp Med Biol 528, 229-30.
37. Mizuki M, Yabuki K, Ota M, et al. (2002) Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behcet's disease. Tissue Antigens 60, 396-9.
38. Lemmel C, Rammensee HG, Stevanovič S (2003) Peptide Motiv of HLA-B*5101 and the linkage to Behcet's disease. In: Zierhut M, Ohno S (eds) Immunology of Behcet's Disease, pp 127-37. Swets & Zeitlinger, Lisse, the Netherlands.
39. Kera J, Mizuki N, Ota M, et al. (1999) Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients. Tissue Antigens 54, 565-71.
40. Paul M, Klein T, Krause I, Molad Y, Narinsky R, Weinberger A (2001) Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behcet's disease. Tissue Antigens 58, 185-6.
41. Samsonov MIU, Prokaeva TB, Madanat V, et al. (1995) Serum neopterin in Behcet's disease. Klin Med 73, 53-5.
42. Keser G, Oksel F, Aksu K, et al. (2000) Serum neopterin levels in Behcet's syndrome. Clin Rheumatol 19, 326-9.
43. Wirleitner B, Neurauter G, Schröcksnadel K, Frick B, Fuchs D (2003) Interferon-γ-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr Med Chem 10, 1401-11.
44. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D (1997) Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43, 2424-6.
45. Kotter I, Koch S, Vonthein S, et al. (2005) Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behcet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol 23(Suppl 38), 20-6.
46. Cuchacovich M, Merino G, Yamamoto JH, et al. (2005) Behcet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation. Clin Exp Rheumatol 23(Suppl 38), 27-34.